CitraFlow™ 4% (Trinatriumcitrat) Die sichere und einfache Methode um jeden Katheter zu blocken

CitraFlow™ 4% 2.5ml vorgefüllte Spritze:

     1.  Antithrombotische Wirkung
     2.  Vermeidung von Biofilm
     3.  Spar Zeit
     4.  Sicher & Keine Nebenwirkungen
     5.  Verhindert durch Heparin ausgelöste Blutungen
     6.  Geringere tPa Beanspruchungsrate und Kosten
     7.  Sicher im Fall von durch Heparin ausgelöster
          Thrombozytopenie (Hit-Patienten)

Box enthält 150 Spritzen

CitraFlow™ (Trisodium citrate 4%)

REFERENZEN:
1. Bayes B et al (1999) Sodium Citrate for filling hemodiaysis catheters. Nephrol Dial Transplant 14, 2532-2533
2. Buturovic J et al (1998) Filling hemodialysis catheters in the interdialytic period. Artif Organs 22, 945-947
3. Grudzinski L et al (2007) Sodium citrate 4% locking solution for central venous dialysis catheters-an effective, more cost-efficient alternative to heparin.
Nephrol Dial Transplant 22: 471-476
4. Hendrickx L et al (2001) A comparative study on the use of low concentrate citrate lock. Int J Artif Organs 24, 208-211
5. Lok CE et al (2005) Trisodium citrate 4%-an alternatieve to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 22, 477-483
6. Meeus G et al (2005) A prospective, randomized, double-blind crossover study on the use of 5% citrate-lock vs 10% citrate-lock. Blood Purif 23, 101-105
7. Michaud D et al (2001) Four percent trisodium citrate as an effective anticoagulant. Am J Crit Care 10, 351-354
8. Moran JE and Ash SE (2008) Locking Solutions for Hemodialysis Catheters; Heparin and Citrate. A Position Paper by ASDIN. Seminars in Dialysis 21,1-3
9. Dreyer G et al (2008) Heparin leak from a hemodialysis catheter causing major bleeding, ultimately leading to transplant rejection and death.
HDI Volume 12, Number 4, October 2008, pp. 431-433(3)

Also Available in 5 ml vials: Citra-LockTM 4%

Citra-Lock™ 4%
Citra-Lock™ 30%
Citra-Lock™ 46,7%

Citra-Lock™ and Citra-Flow™ are registered as a medical device (Class IIb)